Prokar Dasgupta

Prokar Dasgupta is Professor and Chair of Urology at King's College London, Guy's Hospital, King's Health Partners. He was appointed as Consultant Urologist to Guy's Hospital in 2002 where he pioneered robotic urological surgery within the UK.[1] He is credited with developing the technique of injecting Botulinum toxin in overactive bladders.[2][3] He became the first Professor of Robotic Surgery and Urological Innovation at King's College London in 2009 and subsequently the Chairman of the King’s-Vattikuti Institute of Robotic Surgery. His main basic research interest is in the immunology of prostate cancer. He has also contributed to educational excellence by leading surgical simulation within the UK and internationally. He is the former editor-in-chief of the BJU International (BJUI).

Prokar Dasgupta
Professor Prokar Dasgupta.jpg
Born19 November
Rourkela, India
Alma materUniversity of Calcutta
Awards2006 Karl Storz-Harold Hopkins Golden Telescope award, 2012 President, The Hunterian Society
Scientific career
FieldsUrology, robotic surgery
InstitutionsGuy’s Hospital, King's College London

He was awarded the Fellowship of the Linnaean Society (FLS) in 2017 and the Fellowship of King’s College (FKC) in 2018.

He has raised funds and been a Trustee to a number of charities including the Malcolm Coptcoat Trust, The Prostate Cancer Research Centre, UK and The Prostate Cancer Foundation in Kolkata, India.


Dasgupta graduated with a MBBS from the University of Calcutta in 1989. He completed his FRCS in 1994 and FRCS in Urology in 2000. He was a Medical Research Council Fellow which led to an MSc in 1996 and MD from the University of London in 2001.


Dasgupta has over 1100 articles including over 600 peer-reviewed papers as well as 10 books and 25 chapters and an h-index of 65[4].



  1. ^ "Robotic-assisted surgery at Guy's Hospital". Retrieved 2014-04-22.
  2. ^ Harper, M.; Popat, R.B.; Dasgupta, R.; Fowler, C.J.; Dasgupta, P. (2003). "A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity". BJU International. 92 (3): 325–6. doi:10.1046/j.1464-410X.2003.04312.x. PMID 12887493.
  3. ^ Jo Revill, health editor (2003-04-13). "Botox: now it's not just for wrinkles | UK news | The Observer". The Guardian. Retrieved 2014-04-22.
  4. ^